Lx2-32c–loaded polymeric micelles with small size for intravenous drug delivery and their inhibitory effect on tumor growth and metastasis in clinically associated 4T1 murine breast cancer

References

• World Health OrganizationData [homepage on the Internet]GenevaNCD mortality and morbidity Available from: http://www.who.int/gho/ncd/mortality_morbidity/en/Accessed June 29, 2016
   Google Scholar
• World Health OrganizationProgrammes [homepage on the Internet]GenevaWHO position paper on mammography screening Available from: http://www.who.int/cancer/publications/mammography_screening/en/Accessed June 29, 2016
   Google Scholar
• XiaoXWuJTrigiliCEffects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transportBioorg Med Chem Lett201121164852485621764308
   PubMed Web of Science ®Google Scholar
• ZhouQStudies on anti-drug-resistance activities and mechanisms of action of Lx2-32c, a novel taxane [dissertation]BeijingChinese academy of medical sciences & Peking union medical college2012
   Google Scholar
• WangHBLiHYZuoMXLx2-32c, a novel taxane and its antitumor activities in vitro and in vivoCancer Lett20082681899718482796
   PubMed Web of Science ®Google Scholar
• WangHBLiHYFangWSChenXGInhibiting effect of Lx2-32c, one taxane derivant, on the proliferation of human ovary A2780 cellsChin New Drug J20081710833836
   Google Scholar
• GelderblomHVerweijJNooterKSparreboomACremophor EL: the drawbacks and advantages of vehicle selection for drug formulationEur J Cancer200137131590159811527683
   PubMed Web of Science ®Google Scholar
• WaughWNTrisselLAStellaVJStability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containersAm J Hosp Pharm1991487152015241679294
   PubMedGoogle Scholar
• van ZuylenLKarlssonMOVerweijJPharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micellesCancer Chemother Pharmacol200147430931811345647
   PubMed Web of Science ®Google Scholar
• LiYFYangFFChenWA novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading Capacity for docetaxel and well reconstitution characteristics and its anti-metastasis studyChem Pharm Bull20126091146115422976323
   PubMed Web of Science ®Google Scholar
• KaurPNagarajaGMZhengHA mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human diseaseBMC Cancer20121212022452810
   PubMed Web of Science ®Google Scholar
• TaoKFangMAlroyJSahagianGGImagable 4T1 model for the study of late stage breast cancerBMC Cancer2008822818691423
   PubMed Web of Science ®Google Scholar
• GaucherGDufresneMHSantVPKangNMaysingerDLerouxJCBlock copolymer micelles: preparation, characterization and application in drug deliveryJ Controll Release20051091–3169188
   PubMed Web of Science ®Google Scholar
• LiYFJin JinMJShaoSSmall-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer modelBMC Cancer20141432924885518
   PubMed Web of Science ®Google Scholar
• ZhangYHuoMRZhouJPDD Solver: an add-in program for modeling and comparison of drug dissolution profilesAAPS J201012326327120373062
   PubMed Web of Science ®Google Scholar
• MikhailASAllenCBlock copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levelsJ Controll Release20091383214223
   PubMed Web of Science ®Google Scholar
• ZhangXCJacksonJKBurtHMDevelopment of amphiphilic diblock copolymers as micellar carriers of taxolInt J Pharm19961321195206
   Google Scholar
• BurtHMZhangXCToleikisPEmbreeLHunterWLDevelopment of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxelColloids Surf B Biointerfaces1999161–4161171
   Web of Science ®Google Scholar
• KimTYKimDWChungJYPhase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignanciesClin Cancer Res200410113708371615173077
   PubMed Web of Science ®Google Scholar
• LeeKSChungHCImSAMulticenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerBreast Cancer Res Treat2008108224125017476588
   PubMed Web of Science ®Google Scholar
• FjällskogMLFriiLBerghJIs Cremophor EL, solvent for paclitaxel, cytotoxic?Lancet19933428875873
   PubMed Web of Science ®Google Scholar
• NygrenPCsokaKJonssonBThe cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by CremophorELBr J Cancer19957134784817880727
   PubMed Web of Science ®Google Scholar
• CsókaKDharSFridborgHLarssonRNygrenPDifferential activity of Cremophor EL and paclitaxel in patients’ tumor cells and human carcinoma cell lines in vitroCancer1997796122512339070502
   PubMed Web of Science ®Google Scholar
• BéginMEEllsGHorrobinDFPolyunsaturated fatty acid-induced cytotoxicity aganist tumor cells and its relationship to lipid peroxidationJ Natl Cancer Inst19888031881943346910
   PubMedGoogle Scholar
• SiegelILiuTLYaghoubzadehEKeskeyTSGleicherNCytotoxic effects of free acids on ascites tumor cellsJ Natl Cancer Inst19877822712773468290
   PubMedGoogle Scholar
• BurtonAFOncolytic effects of fatty acids in mice and ratsAm J Clin Nutr199153Suppl 4S1082S1086
   Web of Science ®Google Scholar
• ZhouQLiYJinJLx2-32c, a novel taxane derivative, exerts anti-resistance activity by initiating intrinsic apoptosis pathway in vitro and inhibits the growth of resistant tumor in vivoBiol Pharm Bull201235122170217923207769
   PubMed Web of Science ®Google Scholar
• DanZLCaoHQHeXYA pH-responsive host-guest nanosystem loading succinobucol suppresses lung metastasis of breast cancerTheranostics20166343544526909117
   PubMed Web of Science ®Google Scholar
• KangSAHasanNMannAPBlocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasisMol Ther20152361044105425815697
   PubMed Web of Science ®Google Scholar
• QuailDFJoyceJAMicroenvironmental regulation of tumor progression and metastasisNat Med201319111423143724202395
   PubMed Web of Science ®Google Scholar
• GuptaGPMassaguéJCancer metastasis: building a frameworkCell2006127467969517110329
   PubMed Web of Science ®Google Scholar
• LyBHNguyenNPVinh-HungVRapitiEVlastosGLoco-regional treatment in metastatic breast cancer patients: Is there a survival benefit?Breast Cancer Res Treat2010119353754519876731
   PubMed Web of Science ®Google Scholar
• CriscitielloCGiulianoMCuriglianoGSurgery of the primary tumor in de novo metastatic breast cancer: to do or not to do?Eur J Surg Oncol201541101288129226238477
   PubMed Web of Science ®Google Scholar
• RahmanMMohammedSBreast cancer metastasis and the lymphatic systemOncol Lett20151031233123926622656
   PubMed Web of Science ®Google Scholar
• FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
   PubMed Web of Science ®Google Scholar
• SchroederAHellerDAWinslowMMTreating metastatic cancer with nanotechnologyNat Rev Cancer2011121395022193407
   PubMed Web of Science ®Google Scholar
• LiXDongQYanZMPEG-DSPE polymeric micelle for translymphatic chemotherapy of lymph node metastasisInt J Pharm20154871–281625841567
   PubMedGoogle Scholar
• TammelaTSaaristoAHolopainenTPhotodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasisSci Transl Med201136969ra11
   Web of Science ®Google Scholar
• CabralHMatsumotoYMizunoKAccumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on sizeNat Nanotechnol201161281582322020122
   PubMed Web of Science ®Google Scholar
• ReddySTvan der VliesAJSimeoniEExploiting lymphatic transport and complement activation in nanoparticle vaccinesNat Biotechnol200725101159116417873867
   PubMed Web of Science ®Google Scholar
• BonzaniniMMorelliLBonandiniEMLeonardiEPertileRDalla PalmaPCytologic features of triple-negative breast carcinomaCancer Cytopathol2012120640140922833438
   PubMed Web of Science ®Google Scholar
• FayazMSEl-SherifyMSEl-BasmyAClinicopathological features and prognosis of triple negative breast cancer in Kuwait: a comparative/perspective analysisRep Pract Oncol Radiother201319317318124936335
   PubMedGoogle Scholar
• DentRTrudeauMPritchardKITriple-negative breast cancer: clinical features and patterns of recurrenceClin Cancer Res200713154429443417671126
   PubMed Web of Science ®Google Scholar
• CaldarellaACrocettiEBianchiSFemale breast cancer status according to ER, PR and H&ER2 expression: a population based analysisPathol Oncol Res201117375375821479875
   PubMed Web of Science ®Google Scholar
• AndersCKDealAMMillerCRThe prognostic contribution of clinical breast cancer subtype, age and race among patients with breast cancer brain metastasesCancer201111781602161121472708
   PubMed Web of Science ®Google Scholar
• MiZYGuoHTWaiPYGaoCJWeiJPKuoPCDifferential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behaviorJ Biol Chem200427945466594666715347645
   PubMed Web of Science ®Google Scholar
• AslaksonCJMillerFRSelective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumorCancer Res1992526139914051540948
   PubMed Web of Science ®Google Scholar
• PulaskiBAOstrand-RosenbergSReduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccinesCancer Res1998587148614939537252
   PubMed Web of Science ®Google Scholar